APA

Ciaffi L., Koulla-Shiro S., Sawadogo A. B., Ndour C. T., Eymard-Duvernay S., Mbouyap P. R., Ayangma L., Zoungrana J., Gueye N. F. N., Diallo M., Izard S., Bado G., Kane C. T., Aghokeng A. F., Peeters M., Girard P. M., Le Moing V., Reynes J. & Delaporte E. (20180419). Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. : The lancet. HIV.

Chicago

Ciaffi Laura, Koulla-Shiro Sinata, Sawadogo Adrien Bruno, Ndour Cheik Tidiane, Eymard-Duvernay Sabrina, Mbouyap Pretty Rosereine, Ayangma Liliane, Zoungrana Jacques, Gueye Ndeye Fatou Ngom, Diallo Mohamadou, Izard Suzanne, Bado Guillaume, Kane Coumba Toure, Aghokeng Avelin Fobang, Peeters Martine, Girard Pierre Marie, Le Moing Vincent, Reynes Jacques and Delaporte Eric. 20180419. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. : The lancet. HIV.

Harvard

Ciaffi L., Koulla-Shiro S., Sawadogo A. B., Ndour C. T., Eymard-Duvernay S., Mbouyap P. R., Ayangma L., Zoungrana J., Gueye N. F. N., Diallo M., Izard S., Bado G., Kane C. T., Aghokeng A. F., Peeters M., Girard P. M., Le Moing V., Reynes J. and Delaporte E. (20180419). Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. : The lancet. HIV.

MLA

Ciaffi Laura, Koulla-Shiro Sinata, Sawadogo Adrien Bruno, Ndour Cheik Tidiane, Eymard-Duvernay Sabrina, Mbouyap Pretty Rosereine, Ayangma Liliane, Zoungrana Jacques, Gueye Ndeye Fatou Ngom, Diallo Mohamadou, Izard Suzanne, Bado Guillaume, Kane Coumba Toure, Aghokeng Avelin Fobang, Peeters Martine, Girard Pierre Marie, Le Moing Vincent, Reynes Jacques and Delaporte Eric. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. : The lancet. HIV. 20180419.